Position in FATE
as of Mar 31, 2026
· filed Apr 30, 2026
Position Value
$117,220
+$21,490 QoQ
Shares Held
97,684
0.0% QoQ
Ownership
0.084%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in FATE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026HSBC HOLDINGS PLC holds $961,918,485 across 122 Biotechnology names. FATE ranks #101 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
655,443 | $292,681,510 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
323,338 | $249,823,869 | |
| 3 | RPRX |
Royalty Pharma plc
|
1,544,018 | $74,066,541 | |
| 4 | INCY |
Incyte Corp
|
582,368 | $54,812,474 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
89,619 | $29,652,235 | |
| 6 | MRNA |
Moderna, Inc.
|
490,088 | $24,896,468 | |
| 7 | INSM |
INSMED Inc
|
116,456 | $19,042,883 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
227,059 | $15,469,528 |
All Filings in FATE
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $117,220 | 97,684 | Shares | Defined | 2026-04-30 | |
| 2025-12-31 | $95,730 | 97,684 | Shares | Defined | 2026-03-20 | |
| 2025-09-30 | $123,230 | 97,802 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $115,321 | 102,966 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $86,383 | 109,346 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $180,546 | 109,422 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $314,006 | 89,716 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $290,325 | 88,514 | Shares | Defined | 2024-08-12 | |
| 2024-03-31 | $483,933 | 65,931 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $294,513 | 78,747 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $234,031 | 110,392 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $168,280 | 35,353 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $241,725 | 42,408 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $441,921 | 43,798 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $562,423 | 25,097 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $259,545 | 10,474 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $323,380 | 8,341 | Shares | Defined | 2022-05-16 | |
| 2021-06-30 | $366,514 | 4,223 | Shares | Defined | 2021-08-13 | |
| 2020-09-30 | $495,268 | 12,391 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $543,882 | 15,852 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $228,296 | 10,279 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||